Daniel Leonard is the Director of Global Patient Advocacy at uniQure, a pioneering company in gene therapy. In this role Dan works primarily with hemophilia and Huntington’s disease organizations in the US and abroad. In this role Dan serves as an ambassador to the patient community, but also as an internal advocate for patients’ interests. Prior to joining uniQure, Dan spent 16 years at Genzyme, a company known as a leader in patient centricity. Prior to transitioning to Patient Advocacy in 2011, Dan spent 11 years working in Regulatory Affairs, managing a team responsible for registering enzyme replacement therapies and small molecules throughout Asia and the Middle East. With a Masters’ Degree in Japanese Language and Literature, Dan’s primary focus was registering products in Japan. Dan is active in the non-profit world, served on the Board of Directors of an educational non-profit in Cambridge, MA and developed and launched an award-winning community engagement program bringing students into corporate labs to teach them the science of biotechnology.